Farm Bill Markup Signals No Delay to New Hemp Regulations

Congress Marks Up Farm Bill — Hemp Amendment Unlikely to Advance

Congress is marking up the next Farm Bill this week. An amendment proposing an extension to the November 2026 hemp regulations deadline has been filed. However, the chairman of the relevant committee has indicated the amendment is not germane to the committee’s work, making a vote unlikely.

According to Michael Bronstein, President of American Trade Association for Cannabis and Hemp (ATACH), many members of Congress appear reluctant to revisit hemp policy this year. Extending deadlines without simultaneously addressing the “hemp loophole” — the rapidly expanding market of synthetic and intoxicating hemp derivatives — would likely be viewed as tacit approval of that market. That is a vote many lawmakers do not want to take.

Closing the Loophole Is Necessary

Let’s be clear: closing the hemp loophole is necessary.

The 2018 Farm Bill legalized hemp based on a narrow delta-9 THC threshold. That definition unintentionally created space for chemically converted and highly intoxicating cannabinoids to be sold nationwide — often in gas stations, vape shops, and online — without age gates, potency limits, or consistent testing standards.

That was never the intent of federal hemp legalization.

Bringing intoxicating products back under a coherent regulatory framework is not anti-hemp. It is pro-consumer. Intoxicating cannabinoids should be regulated like intoxicants. The most responsible framework for that regulation is state-run cannabis programs and licensed dispensaries, where age verification, potency standards, and compliance oversight already exist.

There will be turbulence. Businesses built around synthetic conversions and gray-market intoxicants will feel it. Supply chains will shift. Some products will disappear. That disruption is real.

But regulatory clarity is healthier than regulatory ambiguity.

What This Means for CBD

The new federal framework is aimed primarily at intoxicating cannabinoids and synthetic derivatives — not at traditional, non-intoxicating hemp extracts. The CBD industry is not being “shut down.” It is being separated from an adjacent market that evolved outside the spirit of the law.

That distinction matters.

Non-intoxicating, THC-free CBD products — especially in states like Idaho — were never part of the loophole problem to begin with. Idaho has long maintained one of the strictest cannabis policies in the country, allowing only THC-free hemp extracts for retail sale. In many ways, Idaho retailers have already been operating under a stricter standard than what federal regulators are now moving toward.

Our Position in Idaho

At Herbal Edge, we support closing the loophole.

Intoxicating products belong in licensed dispensaries with proper oversight. Hemp-derived intoxicants should not be sold in convenience stores under a regulatory gray cloud.

We also recognize the turbulence ahead. That’s why we are proactively securing Idaho-compliant inventory for 2027 and beyond — focusing on verified THC-free formulations, documented third-party testing, and supply agreements that meet both state and anticipated federal standards.

This is not a death sentence for responsible CBD businesses. It is a reset. And long term, clarity is better than chaos.

Continue Reading

If you’d like to understand how we arrived at this moment:

• Read our breakdown of the hemp loophole and how federal definitions unintentionally created today’s synthetic intoxicant market.

• See our recent analysis of developments in Boise and how local enforcement and policy shifts are shaping Idaho’s retail environment.

• Explore our Idaho CBD Consumer Guide for a clear explanation of what is legally available in this state and how to evaluate compliant, non-intoxicating products responsibly. (Coming Soon)

Regulatory clarity separates responsible hemp companies from opportunistic ones. We intend to be here when the dust settles.